Results 101 to 110 of about 396,801 (209)

LncRNA CRNDE triggers inflammation through the TLR3-NF-κB-Cytokine signaling pathway

Tumor Biology, 2017
Colorectal neoplasia differentially expressed (CRNDE), an oncogene, is highly expressed in many tumor cells and affects cellular proliferation, migration, invasion, and apoptosis. Its function and mechanism of action is a research hotspot. In this study,
Haowen Li, Qi Li, Tao Guo, Wenyan He, Chengya Dong, Yajie Wang   +5 more
doaj   +1 more source

Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update [PDF]

, 2019
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public health problem. It is considered to be the hepatic manifestation of the metabolic syndrome.
Breaban, Iulia, Coste, Sorina Cezara, Cozma, Angela, Negrean, Vasile, Orasan, Olga Hilda, Popovici, Ionela, Procopciuc, Lucia Maria, Sampelean, Dorel, Sitar Taut, Adela, Stefan, Andreea Maria, Tarmure Sarlea, Simina   +10 more
core   +1 more source

Toll-like receptors and diseases [PDF]

International Immunopharmacology, 2011
Pablo, Iribarren, Ji Ming, Wang
openaire   +2 more sources

The role of hypoxia and complement receptor 2 or toll-like receptor 2 on B1 B cell effector function [PDF]

Master of ScienceDivision of BiologySherry D. FlemingProfessional phagocytes play a critical role in maintaining homeostasis within a host through phagocytic, microbicidal, and inflammatory activity.
Knights, Kaori
core   +1 more source

Toll-like Receptor Signaling [PDF]

Journal of Biological Chemistry, 2003
openaire   +2 more sources

Toll-like receptor signaling outcome is determined by the stoichiometry of the endogenous TRIFosome. [PDF]

Sci Adv
Moncrieffe MC, Suresh P, Boyle J, Cui Y, Nawalpuri B, Verstak B, Zhang YP, Zhang Z, Taylor M, Egelman EH, Gay N, Klenerman D, Bryant C.   +12 more
europepmc   +1 more source

The Role of Toll-like Receptor 2 Polymorphisms in Susceptibility to and Severity of Tuberculosis: A Systematic Review. [PDF]

Pathogens
Sudarto S, Hafy Z, Saleh I, Liberty I, Ahmad Z, Lubis FZ, Hu O, Arista B.   +7 more
europepmc   +1 more source

Development of nanoparticle-based Toll-like receptor agonists for respiratory immunotherapy. [PDF]

EXCLI J
Raikar AS, Verma A, Naik MB, Prabhu SM, Paudel KR, Dua K.   +5 more
europepmc   +1 more source

Different toll like receptor (TLR) expression patterns in progression towards cancer

Frontiers in Immunology, 2014
Lauri eJouhi, Suvi eRenkonen, Timo eAtula, Antti eMäkitie, Caj eHaglund, Jaana eHagström   +5 more
doaj   +1 more source

Bacterial Communities as Modulators of Innate Immune Signalling: An In Vitro Perspective on Toll-Like Receptor Activation. [PDF]

Environ Microbiol Rep
Eriksen E, Graff P, Afanou AK.
europepmc   +1 more source